Introduction Canine meningoencephalitis of unknown origin (MUO) is a debilitating disease
associated with high mortality. The prognostic value of magnetic resonance imaging (MRI) …

Background Meningoencephalitis of unknown origin (MUO) comprises a group of
noninfectious inflammatory diseases affecting the central nervous system of dogs. Previous …

Gliomas are the second most common primary brain tumor in dogs and although they are
associated with a poor prognosis, limited data are available relating to the efficacy of …

A 2.5-year-old female entire Pomeranian dog was presented for acute paraparesis
progressing within 2 days to paraplegia. General physical examination was unremarkable …

Background The prognosis of individual dogs with meningoencephalomyelitis of unknown
etiology (MUE) remains difficult to predict. MUE cases with no lesions detected by magnetic …

Background Meningoencephalitis of unknown origin is a common cause of severe
neurological disease in dogs. The term covers a heterogeneous group of noninfectious …

This retrospective study evaluated canine patients with presumptively diagnosed
meningoencephalomyelitis (ME) based on neurological clinical signs, cerebrospinal fluid …

Simple Summary Crisdesalazine is a multi-targeted drug with antioxidant and anti-
inflammatory action to prevent amyloid plaque, neurofibrillary tangle, and …

Traditional purpose-bred laboratory animals used in clinical research and testing often do
not represent human conditions, with efficacy results often not replicated in human clinical …

Abstract A 1‐year 5‐month‐old, female, entire Parson Russell terrier was referred for
investigations of focal epileptic seizures and behavioural changes. The clinical signs started …